What's new

Human medicines European public assessment report (EPAR): Neuraceq, florbetaben (18F), Date of authorisation: 20/02/2014, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Neuraceq, florbetaben (18F), Date of authorisation: 20/02/2014, Revision: 24, Status: Authorised

Jun 23, 2025 - 13:50
 0
Human medicines European public assessment report (EPAR): Neuraceq, florbetaben (18F), Date of authorisation: 20/02/2014, Revision: 24, Status: Authorised
Human medicines European public assessment report (EPAR): Neuraceq, florbetaben (18F), Date of authorisation: 20/02/2014, Revision: 24, Status: Authorised
Read More

Tags:

Previous Article

EMEA-002875-PIP02-24

Next Article

Human medicines European public assessment report (EPAR): Grepid, clopidogrel, D...

Related Posts

Human medicines European public assessment report (EPAR): Targretin, bexarotene, Date of authorisation: 29/03/2001, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR...

May 12, 2025  0

Human medicines European public assessment report (EPAR): Sixmo, buprenorphine, Date of authorisation: 19/06/2019, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

May 28, 2025  0

EMEA-003624-PIP01-24

EMEA-003624-PIP01-24

Jun 11, 2025  0